BRISTOL-MYERS SQUIBB COMPANY Restructuring Reserve, Current
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Restructuring Reserve, Current of $24.00 million as of 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2019-10-31
- 2019-09-30: Restructuring Reserve, Current $24.00M.
- 2019-06-30: Restructuring Reserve, Current $38.00M.
- 2019-03-31: Restructuring Reserve, Current $53.00M.
- 2018-12-31: Restructuring Reserve, Current $85.00M.
| Period end | Restructuring Reserve, Current |
|---|---|
| 2019-09-30 | $24.00M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $38.00M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $53.00M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $85.00M 10-Q · filed 2019-10-31 |
| 2018-09-30 | $102.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $79.00M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $113.00M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $155.00M 10-K · filed 2019-02-25 |
| 2017-09-30 | $121.00M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $153.00M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $182.00M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $90.00M 10-K · filed 2018-02-13 |
| 2016-09-30 | $60.00M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $58.00M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $66.00M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $89.00M 10-K · filed 2017-02-21 |
| 2014-12-31 | $128.00M 10-K · filed 2016-02-12 |
| 2013-12-31 | $73.00M 10-K · filed 2015-02-13 |
| 2012-12-31 | $120.00M 10-K · filed 2014-02-14 |
| 2011-12-31 | $58.00M 10-K · filed 2013-02-15 |
| 2010-12-31 | $108.00M 10-K · filed 2012-02-17 |
| 2009-12-31 | $142.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |